Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

Oncolytic viruses represent a promising therapeutic modality, but they have yet to live up to their therapeutic potential. Safety and efficacy concerns impel us to identify least toxic oncolytic agents that would generate durable and multifaceted anti-tumor immune responses to disrupt the tumors. He...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncoimmunology
Huvudupphovsmän: Luo, Yong, Lin, Chaolong, Zou, Yidi, Ju, Fei, Ren, Wenfeng, Lin, Yanhua, Wang, Yale, Huang, Xiaoxuan, Liu, Huiling, Yu, Zeng, Liu, Pingguo, Tan, Guowei, Yuan, Quan, Zhang, Jun, Huang, Chenghao, Xia, Ningshao
Materialtyp: Artigo
Språk:Inglês
Publicerad: Taylor & Francis 2020
Ämnen:
Original Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7028326/
https://ncbi.nlm.nih.gov/pubmed/32117591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2020.1726168
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk